- Home
- OTLK vs BMR Comparison
OTLK vs BMR Comparison
Compare OTLK & BMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OTLK
- BMR
- Stock Information
- Founded
- OTLK 2010
- BMR 2009
- Country
- OTLK United States
- BMR Israel
- Employees
- OTLK N/A
- BMR N/A
- Industry
- OTLK Biotechnology: Biological Products (No Diagnostic Substances)
- BMR Computer Software: Prepackaged Software
- Sector
- OTLK Health Care
- BMR Technology
- Exchange
- OTLK Nasdaq
- BMR Nasdaq
- Market Cap
- OTLK 48.3M
- BMR 41.9M
- IPO Year
- OTLK 2016
- BMR 2023
- Fundamental
- Price
- OTLK $0.93
- BMR $2.78
- Analyst Decision
- OTLK Buy
- BMR
- Analyst Count
- OTLK 5
- BMR 0
- Target Price
- OTLK $8.50
- BMR N/A
- AVG Volume (30 Days)
- OTLK 7.8M
- BMR 1.0M
- Earning Date
- OTLK 08-14-2025
- BMR 08-13-2025
- Dividend Yield
- OTLK N/A
- BMR N/A
- EPS Growth
- OTLK N/A
- BMR N/A
- EPS
- OTLK N/A
- BMR N/A
- Revenue
- OTLK $1,505,322.00
- BMR $3,131,000.00
- Revenue This Year
- OTLK N/A
- BMR $21.21
- Revenue Next Year
- OTLK $484.88
- BMR N/A
- P/E Ratio
- OTLK N/A
- BMR N/A
- Revenue Growth
- OTLK N/A
- BMR 5.96
- 52 Week Low
- OTLK $0.79
- BMR $1.86
- 52 Week High
- OTLK $8.32
- BMR $6.59
- Technical
- Relative Strength Index (RSI)
- OTLK 31.89
- BMR 42.69
- Support Level
- OTLK $0.82
- BMR $2.60
- Resistance Level
- OTLK $0.98
- BMR $3.00
- Average True Range (ATR)
- OTLK 0.27
- BMR 0.21
- MACD
- OTLK -0.15
- BMR -0.02
- Stochastic Oscillator
- OTLK 5.25
- BMR 18.18
About OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.
About BMR Beamr Imaging Ltd.
Beamr Imaging Ltd is a video technology and image science software company. It is an innovator of video encoding, transcoding, and optimization solutions that enable high quality, performance, and unmatched bitrate efficiency for video and images. The company is conducted through one operating segment, the optimization technology for video and photo compression. The company operates in Israel, the United States, and the rest of the world, it derives a majority of its revenue from the United States.